Board of Directors
The Board of Directors consists of each of the three co-founders (Martin, Knighton, and Jeffery F. Miller) and Mr. Kevin Cameron, who was elected to the board in 2007.
Kevin brings a strong entrepreneurial, legal and transactional background. JD, University of Chicago; General Counsel for Moxidigital and North Pointe Communications; Co-founder and President of Glass, Lewis and Company, a significant worldwide shareholder services company.
James L. Knighton
MBA, Wharton School of Business, MS. Genetics, University of Pennsylvania; R&D, marketing and finance at the following companies: DuPont/DuPont Merck (1985-1994), Chiron (1994-1998), Sugen – CFO (1998-1999) and Caliper Life Sciences, President (1999-2004).
David W. Martin, MD
Duke Medical School; Professor of Medicine and Biochemistry, UCSF and Investigator, Howard Hughes Medical Institute; SVP of R&D at Genentech (1982-1990); Executive VP of R&D at DuPont Merck (1991-1993); President, Chiron Therapeutics (1994-1995) and founder and CEO of Eos Biotechnology (1997-2003).
Jeffery F. Miller, Ph.D.
Pylum’s third co-founder, is consultant and chairman of the company’s Scientific Advisory Board. Currently, Dr. Miller is M. Philip Davis Chair of the Department of Microbiology, Immunology & Molecular Genetics, David Geffen School of Medicine at UCLA. His Ph.D. is from Tufts University School of Medicine, and his postdoctoral experience was at Stanford University School of Medicine with Professors Stanley Falkow and Lucy Tompkins.
DuPont Ventures, Managing Director
DuPont Emerging Innovation
Experimental Station 356/236B
200 Powder Mill Road
Wilmington, DE 19803